A carregar...
Management of Fibrosing Interstitial Lung Diseases
A proportion of patients with interstitial lung diseases (ILDs), including the ILDs that are commonly associated with autoimmune diseases, develop a progressive fibrosing phenotype characterised by worsening of lung function, dyspnoea and quality of life, and early mortality. No drugs are approved f...
Na minha lista:
| Publicado no: | Adv Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Healthcare
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6824393/ https://ncbi.nlm.nih.gov/pubmed/31119691 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-019-00992-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|